Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Apostolia Maria Tsimberidou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2713-233X; OpenAlex author ID A5044840107. Sources: ClinicalTrials.gov.

Their work

Papers
4 (first author 2, last author 1)
Trials
4 (principal investigator on 4)
Grants
0
Labs led
0
Collaborators
19
Papers, trials and grants by year

2010: 1 trial · 2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: 1 paper · 2018: 2 trials · 2019: 1 trial · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 4

  1. Synergistic cytotoxicity of histone deacetylase and poly-ADP ribose polymerase inhibitors and decitabine in pancreatic cancer cells: Implications for novel the… First author DOI 10.18632/oncotarget.28588↗
  2. Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experience. Co-author DOI 10.18632/oncotarget.19897↗
  3. Gene and cell therapy for pancreatic cancer. Last author DOI 10.1517/14712598.2015.1001734↗
  4. Phase 1 clinical trials in 83 patients with pancreatic cancer: The M. D. Anderson Cancer Center experience. First author DOI 10.1002/cncr.25346↗

Trials 4

  1. Phase 1/2 Study of OBI-999 in Patients With Advanced Solid Tumors Principal investigator NCT04084366↗
  2. This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors. Principal investigator NCT03573544↗
  3. A Phase I/II Study of OBI-3424 in Subjects with Advanced Solid Tumors Principal investigator NCT03592264↗
  4. Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX) Principal investigator NCT01183663↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Benigno C. Valdez · 1 shared paper, 2024 · strength 0.23
  2. Börje S. Andersson · 1 shared paper, 2024 · strength 0.23
  3. Hans Martin Singh · 1 shared paper, 2015 · strength 0.08
  4. Guy Ungerechts · 1 shared paper, 2015 · strength 0.08
  5. Robert A. Wolff · 2 shared papers, 2011–2017 · strength 0.08
  6. David S. Hong · 2 shared papers, 2011–2017 · strength 0.08
  7. Aung Naing · 2 shared papers, 2011–2017 · strength 0.08
  8. Funda Meric-Bernstam · 1 shared paper, 2017 · strength 0.05
  9. Milind M. Javle · 1 shared paper, 2017 · strength 0.05
  10. Sarina Anne Piha-Paul · 1 shared paper, 2017 · strength 0.05
  11. Jennifer Brooke Goldstein · 1 shared paper, 2017 · strength 0.05
  12. Chad Z. Tang · 1 shared paper, 2017 · strength 0.05
  13. Kenneth R. Hess · 1 shared paper, 2017 · strength 0.05
  14. Gauri Rajani Varadhachary · 1 shared paper, 2017 · strength 0.05
  15. Vivek Subbiah · 1 shared paper, 2017 · strength 0.05
  16. David R. Fogelman · 1 shared paper, 2017 · strength 0.05
  17. Siqing Fu · 1 shared paper, 2017 · strength 0.05
  18. Christos Vaklavas · 1 shared paper, 2011 · strength 0.03
  19. Razelle Kurzrock · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.